Targeting small cell lung cancer by focal adhesion kinase inhibitor GSK2256098
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110319
- Recipient
-
The Ohio State University UEI DLWBSLWAJWR1 Part of The Ohio State University
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $156,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Columbus, OH 43210, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $156,000 Project Grant to The Ohio State University Office of Sponsored Programs under the Military Medical Research and Development program. The grant will fund research from June 2021 to June 2023 to target small cell lung cancer through inhibition of focal adhesion kinase using the investigational drug GSK2256098. As part of the Military Medical Research and Development program's goal of transforming military and public health through innovative medical research solutions, this award will support applied biomedical research investigating potential new treatment approaches for small cell lung cancer.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $156,000 |
Quick answers
Who received award W81XWH2110319?
W81XWH2110319 was awarded to The Ohio State University by Medical Command (Department of the Army) on June 15, 2021.
How much is award W81XWH2110319 worth?
$156,000 has been obligated on W81XWH2110319.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award